Coya Therapeutics grants stock options to CEO, President/CMO, and CFO/COO

Coya Therapeutics, Inc.

CEO Howard Berman granted options to purchase 165,000 shares at $3.85 per share.
President/CMO Adrian Hepner and CFO/COO David Snyder each granted options for 115,000 shares.
Options vest in 36 equal monthly installments with full acceleration on change of control.
Options expire 10 years from grant date; exercise price equals closing price on grant date.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.